Deuteroncology
Liege, BE · Founded 2022 · 101 employees on LinkedIn · 1 known investors
Find your way into Deuteroncology
Sign up to see every warm intro you have to Deuteroncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deuteroncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DeuterOncology is a clinical-stage biotech developing DO-2, a deuterated, brain-penetrant MET kinase and RAS pathway inhibitor for cancer patients, currently in a phase 1 clinical study. The molecule was in-licensed from OCTIMET Oncology and originally from Janssen Pharmaceutica.
Founders & leadership
Deuteroncology was founded in 2022 by Timothy Perera.
TP
Timothy PereraPhD Founder & CEOTimothy Perera holds a Ph.D. in Cell Biology and has over 30 years of experience in oncology drug development. He previously served as Chief Scientific Officer and Founder of OCTIMET Oncology, a company he spun out from Janssen Pharmaceuticals where he had been Senior Director of Oncology Discovery, and now leads DeuterOncology as Founder and CEO.
Investors · 1
Newton Biocapital✓ confirmed by DeuteroncologyBrussels
How we know: Newton Biocapital's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Deuteroncology do?
- DeuterOncology is a clinical-stage biotech developing DO-2, a deuterated, brain-penetrant MET kinase and RAS pathway inhibitor for cancer patients, currently in a phase 1 clinical study. The molecule was in-licensed from OCTIMET Oncology and originally from Janssen Pharmaceutica.
- Who founded Deuteroncology?
- Deuteroncology was founded by Timothy Perera in 2022.
- Who are Deuteroncology's investors?
- Deuteroncology's investors include Newton Biocapital.
- Where is Deuteroncology headquartered?
- Deuteroncology is headquartered in Liege, BE.
